Here are the top IVBM articles from 2025 capturing how value-based strategies are translating into real-world impact. Click ...
To wrap up this year's author podcast series, The American Journal of Managed Care® speaks with Angela Liu, PhD, MPH, ...
CKD complicates cancer treatment, reducing adjuvant chemotherapy use and increasing mortality risk, necessitating ...
Soefje also discusses the growing role of pharmacists, technology, and comparative efficacy data in improving adherence, ...
Key challenges include logistical hurdles, such as the need for specialized training and infrastructure, and financial ...
Highlights of the conference coverage from the 2025 European Society of Medical Oncology (ESMO) Congress included content on ...
At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 ...
Sonrotoclax demonstrated a total overall response rate of 52%, including a complete response rate of 16%. However, Wang ...
Managed care organizations must prioritize dextromethorphan-bupropion based on sustained efficacy, improved remission rates, ...
Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...
The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...
Our top 5 heart failure articles of 2025 include FDA approvals, improving guideline-directed medical therapy (GDMT), markers of progressive heart failure (HF) such as findings from echocardiogram ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback